Skip to main content
Equibles

NOMURA ASSET MANAGEMENT INTERNATIONAL INC.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 921739 PHILADELPHIA, PA
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,974,262
+$852,856 QoQ
Shares Held
136,250
+68.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 238 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NOMURA ASSET MANAGEMENT INTERNATIONAL INC. holds $328,855,026 across 12 Drug Manufacturers - Specialty & Generic names. RDY ranks #11 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SUPN
Supernus Pharmaceuticals, Inc.
 2,378,329 $110,616,081
2 LNTH
Lantheus Holdings, Inc.
 671,042 $74,445,399
3 NBIX
Neurocrine Biosciences Inc
 222,554 $37,509,251
4 ZTS
Zoetis Inc.
 385,327 $27,689,598
5 ANIP
Ani Pharmaceuticals Inc
 287,206 $23,774,912
6 VTRS
Viatris Inc
 1,308,106 $20,772,723
7 ALKS
Alkermes plc.
 337,043 $17,661,053
8 HIMS
Hims & Hers Health, Inc.
 229,581 $7,959,573

All Filings in RDY

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,974,262 136,250
2026-03-31 $1,121,406 80,968
2025-12-31 $676,924 48,214